285 related articles for article (PubMed ID: 31913060)
1. Potential impact of removing metronidazole from treatment armamentarium of mild acute
Zilberman-Itskovich S; Youngster I; Lazarovitch T; Bondarenco M; Toledano L; Kachlon Y; Mengesha B; Strul N; Zaidenstein R; Marchaim D
Future Microbiol; 2019 Nov; 14():1489-1495. PubMed ID: 31913060
[No Abstract] [Full Text] [Related]
2. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
Gentry CA; Campbell DL; Williams RJ
Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
[TBL] [Abstract][Full Text] [Related]
3. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
Stevens VW; Khader K; Echevarria K; Nelson RE; Zhang Y; Jones M; Timbrook TT; Samore MH; Rubin MA
Clin Infect Dis; 2020 Jul; 71(3):645-651. PubMed ID: 31504328
[TBL] [Abstract][Full Text] [Related]
4. [THE EPIDEMIOLOGY OF CLOSTRIDIUM DIFFICILE INFECTIONS AND ASPECTS PERTAINING TO TREATMENT WITH VANCOMYCIN AT ASSAF HAROFEH MEDICAL CENTER].
Youngster I; Lazarovitch T; Bondorenco M; Kachlon Y; Toledano L; Mengesha B; Zaidenstein R; Daniel C; Dadon M; Marchaim D
Harefuah; 2018 May; 157(5):305-308. PubMed ID: 29804335
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
[TBL] [Abstract][Full Text] [Related]
6. Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
Igarashi Y; Tashiro S; Enoki Y; Taguchi K; Matsumoto K; Ohge H; Suzuki H; Nakamura A; Mori N; Morinaga Y; Yamagishi Y; Yoshizawa S; Yanagihara K; Mikamo H; Kunishima H
J Infect Chemother; 2018 Nov; 24(11):907-914. PubMed ID: 30170735
[TBL] [Abstract][Full Text] [Related]
7. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
[TBL] [Abstract][Full Text] [Related]
8. The Rise and Fall of Metronidazole for Clostridium difficile Infection.
Chahine EB
Ann Pharmacother; 2018 Jun; 52(6):600-602. PubMed ID: 29424238
[TBL] [Abstract][Full Text] [Related]
9. High frequency of nonadherence to Clostridium difficile treatment guidelines.
McEllistrem MC; McGraw M; Sahud AG; Chan-Tompkins NH; Goswami R; Bhanot N
South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
Na'amnih W; Adler A; Miller-Roll T; Cohen D; Carmeli Y
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1281-1288. PubMed ID: 29627951
[TBL] [Abstract][Full Text] [Related]
11. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
Kimura T; Snijder R; Sugitani T
J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J
Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244
[TBL] [Abstract][Full Text] [Related]
13. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
[TBL] [Abstract][Full Text] [Related]
14. What Is the Role for Metronidazole in the Treatment of Clostridium difficile Infection? Results From a National Cohort Study of Veterans With Initial Mild Disease.
Appaneal HJ; Caffrey AR; LaPlante KL
Clin Infect Dis; 2019 Sep; 69(8):1288-1295. PubMed ID: 30561531
[TBL] [Abstract][Full Text] [Related]
15. Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile.
Early CR; Park JM; Dorsch MP; Pogue KT; Hanigan SM
Transpl Infect Dis; 2016 Oct; 18(5):714-720. PubMed ID: 27501504
[TBL] [Abstract][Full Text] [Related]
16. [Individualized treatment strategies for Clostridium difficile infections].
Solbach P; Dersch P; Bachmann O
Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection.
Vega AD; Heil EL; Blackman AL; Banoub M; Kristie Johnson J; Leekha S; Claeys KC
Pharmacotherapy; 2020 May; 40(5):398-407. PubMed ID: 32246501
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin Versus Metronidazole for Nonsevere
Sarna KV; Gross AE
Ann Pharmacother; 2019 Aug; 53(8):845-852. PubMed ID: 30734567
[No Abstract] [Full Text] [Related]
19. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
[TBL] [Abstract][Full Text] [Related]
20. The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan.
Ishii S; Muraki Y; Kusama Y; Yagi T; Goto R; Ebisui A; Kawabe A; Inose R; Ohmagari N
Biol Pharm Bull; 2020; 43(4):693-696. PubMed ID: 32238711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]